SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 277 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $547,000 | -3.2% | 16,933 | -0.8% | 0.01% | +11.1% |
| Q1 2022 | $565,000 | -15.8% | 17,067 | +8.1% | 0.01% | -10.0% |
| Q4 2021 | $671,000 | -12.2% | 15,782 | -8.5% | 0.01% | -23.1% |
| Q3 2021 | $764,000 | +3.0% | 17,239 | +67.6% | 0.01% | -23.5% |
| Q4 2019 | $742,000 | +265.5% | 10,283 | +824.7% | 0.02% | +240.0% |
| Q2 2019 | $203,000 | – | 1,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |